Ignite Creation Date:
2024-05-06 @ 7:20 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05978401
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-07
First Post:
2023-07-26
Brief Title:
Safety Tolerability and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer
Sponsor:
Guangzhou Gloria Biosciences Co Ltd
Organization:
Guangzhou Gloria Biosciences Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-26
First Submit QC Date:
August 3 2023
Study First Post Date:
2023-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-03
Last Update Post Date:
2023-08-07
Last Update Post Date Type:
ACTUAL